Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease. uri icon

authors

  • Koomen, Jeroen V
  • Parving, Hans-Henrik
  • Perkovic, Vlado
  • Tobe, Sheldon W
  • de Zeeuw, Dick
  • Heerspink, Hiddo J L
  • Stevens, Jasper
  • Bakris, George
  • Correa-Rotter, Ricardo
  • Hou, Fan Fan
  • Dalane W Kitzman, MD
  • Kohan, Donald E
  • Makino, Hirofumi
  • McMurray, John J V

publication date

  • January 1, 2021